Q9NZT2 (OGFR_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 97.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Opioid growth factor receptor Short name=OGFr Alternative name(s): Protein 7-60 Zeta-type opioid receptor | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 677 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation. |
| Subcellular location | Cytoplasm By similarity. Nucleus By similarity. Note: The OGF/OGFR complex is probably translocated to the nucleus. |
| Tissue specificity | Highly expressed in the heart and liver, moderately in skeletal muscle and kidney and to a lesser extent in brain and pancreas. Expressed in fetal tissues including liver and kidney. |
| Post-translational modification | Phosphorylated upon DNA damage, probably by ATM or ATR. Ref.7 Ref.8 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.15 |
| Sequence similarities | Belongs to the opioid growth factor receptor family. |
| Sequence caution | The sequence AAD03737.1 differs from that shown. Reason: Frameshift at positions 1 and 181. The sequence AAD03745.1 differs from that shown. Reason: Frameshift at positions 1 and 181. The sequence CAC28882.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Growth regulation |
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Repeat |
| Molecular function | Receptor |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | regulation of cell growth Non-traceable author statement Ref.1. Source: UniProtKB |
| Cellular component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell membraneInferred from electronic annotation. Source: InterPro nucleusInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | opioid receptor activity Non-traceable author statement Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9NZT2-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9NZT2-2) The sequence of this isoform differs from the canonical sequence as follows: 558-577: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 677 | 677 | Opioid growth factor receptor | PRO_0000058030 | |||||
Regions | |||||||||
| Repeat | 517 – 536 | 20 | 1 | ||||||
| Repeat | 537 – 556 | 20 | 2 | ||||||
| Repeat | 557 – 576 | 20 | 3 | ||||||
| Repeat | 577 – 596 | 20 | 4 | ||||||
| Repeat | 597 – 616 | 20 | 5 | ||||||
| Repeat | 617 – 636 | 20 | 6 | ||||||
| Repeat | 637 – 656 | 20 | 7 | ||||||
| Region | 517 – 656 | 140 | 7 X 20 AA approximate tandem repeats of [ST]-P-S-E-T-P-G-P-[SR]-P-A-G-P-[AT]-[GR]-D-E-P-A-[EK] | ||||||
| Motif | 267 – 283 | 17 | Bipartite nuclear localization signal Potential | ||||||
Amino acid modifications | |||||||||
| Modified residue | 1 | 1 | N-acetylmethionine Ref.13 | ||||||
| Modified residue | 315 | 1 | Phosphoserine Ref.7 Ref.8 Ref.13 Ref.15 | ||||||
| Modified residue | 349 | 1 | Phosphoserine Ref.11 Ref.15 | ||||||
| Modified residue | 361 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 378 | 1 | Phosphoserine Ref.7 Ref.10 Ref.11 Ref.12 Ref.14 Ref.15 | ||||||
| Modified residue | 420 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 484 | 1 | Phosphoserine Ref.11 | ||||||
Natural variations | |||||||||
| Alternative sequence | 558 – 577 | 20 | Missing in isoform 2. | VSP_004060 | |||||
| Natural variant | 545 | 1 | R → S. Corresponds to variant rs6122313 [ dbSNP | Ensembl ]. | VAR_059706 | |||||
| Natural variant | 577 | 1 | S → T. Ref.1 Ref.2 Ref.5 Corresponds to variant rs6122315 [ dbSNP | Ensembl ]. | VAR_030011 | |||||
Experimental info | |||||||||
| Sequence conflict | 27 – 28 | 2 | DG → EA Ref.2 | ||||||
| Sequence conflict | 37 – 80 | 44 | DAGDE…RHNYP → GARRALGVLGQPGGLQMRLP ERHGGPQGSLCLMDPCCPLS LALQ Ref.5 | ||||||
| Sequence conflict | 50 – 52 | 3 | AAR → GPE Ref.2 | ||||||
| Sequence conflict | 172 | 1 | E → A Ref.2 | ||||||
| Sequence conflict | 220 – 221 | 2 | LG → PC in AAF64404. Ref.1 | ||||||
| Sequence conflict | 220 – 221 | 2 | LG → PC in AAF64405. Ref.1 | ||||||
| Sequence conflict | 224 | 1 | G → S in AAF64404. Ref.1 | ||||||
| Sequence conflict | 224 | 1 | G → S in AAF64405. Ref.1 | ||||||
| Sequence conflict | 224 | 1 | G → S in AAF64406. Ref.1 | ||||||
| Sequence conflict | 240 | 1 | T → S in AAD03745. Ref.2 | ||||||
| Sequence conflict | 240 | 1 | T → S in AAD03737. Ref.2 | ||||||
| Sequence conflict | 262 | 1 | R → G in AAD03745. Ref.2 | ||||||
| Sequence conflict | 262 | 1 | R → G in AAD03737. Ref.2 | ||||||
| Sequence conflict | 331 | 1 | G → E in AAF64406. Ref.1 | ||||||
| Sequence conflict | 398 | 1 | E → G in AAF64406. Ref.1 | ||||||
| Sequence conflict | 465 | 1 | A → T in AAF64406. Ref.1 | ||||||
| Sequence conflict | 535 | 1 | A → AKTPSETPGPSPAGPTRDEP A in AAF64405. Ref.1 | ||||||
| Sequence conflict | 564 | 1 | P → L in AAF64404. Ref.1 | ||||||
| Sequence conflict | 576 | 1 | E → K in AAF64406. Ref.1 | ||||||
| Sequence conflict | 576 | 1 | E → K Ref.2 | ||||||
| Sequence conflict | 576 | 1 | E → K in BAB15775. Ref.5 | ||||||
| Sequence conflict | 577 | 1 | S → I in AAF64406. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans." Zagon I.S., Verderame M.F., Allen S.S., McLaughlin P.J. Brain Res. 856:75-83(2000) [PubMed: 10677613] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANT THR-577. Tissue: Placenta. |
| [2] | "Genomic structure of human gene 7-60." Takanosu M., Liu J., Mayne R., Wood B.M., Brewton R.G. Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), VARIANT THR-577. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Skin. |
| [5] | "Characterization of long cDNA clones from human adult spleen." Hattori A., Okumura K., Nagase T., Kikuno R., Hirosawa M., Ohara O. DNA Res. 7:357-366(2000) [PubMed: 11214971] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 37-677 (ISOFORM 1), VARIANT THR-577. Tissue: Spleen. |
| [6] | "The biology of the opioid growth factor receptor (OGFr)." Zagon I.S., Verderame M.F., McLaughlin P.J. Brain Res. Brain Res. Rev. 38:351-376(2002) [PubMed: 11890982] [Abstract] Cited for: REVIEW. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315 AND SER-378, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [9] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed: 17525332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-420, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [10] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed: 19367720] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, MASS SPECTROMETRY. Tissue: T-cell. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349; SER-361; SER-378 AND SER-484, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography." Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J. Proteomics 8:1346-1361(2008) [PubMed: 18318008] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, MASS SPECTROMETRY. Tissue: Liver. |
| [13] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [14] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-315; SER-349 AND SER-378, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia OGFr entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF172451 mRNA. Translation: AAF64404.1. AF172452 mRNA. Translation: AAF64405.1. AF172453 mRNA. Translation: AAF64406.1. AF112980 Genomic DNA. Translation: AAD03745.1. Frameshift. AF109134 mRNA. Translation: AAD03737.1. Frameshift. AL035669 Genomic DNA. Translation: CAC28882.1. Sequence problems. AL035669 Genomic DNA. Translation: CAI95763.1. BC014137 mRNA. Translation: AAH14137.1. AK024485 mRNA. Translation: BAB15775.1. |
| IPI | IPI00021537. IPI00216130. |
| RefSeq | NP_031372.2. NM_007346.2. |
| UniGene | Hs.67896. |
3D structure databases | |
| ProteinModelPortal | Q9NZT2. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | Q9NZT2. |
PTM databases | |
| PhosphoSite | Q9NZT2. |
Polymorphism databases | |
| DMDM | 146331047. |
Proteomic databases | |
| PRIDE | Q9NZT2. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000290291; ENSP00000290291; ENSG00000060491. |
| GeneID | 11054. |
| KEGG | hsa:11054. |
| UCSC | uc002ydj.1. human. |
Organism-specific databases | |
| CTD | 11054. |
| GeneCards | GC20P061436. |
| H-InvDB | HIX0015988. |
| HGNC | HGNC:15768. OGFR. |
| HPA | HPA017899. |
| MIM | 606459. gene. |
| neXtProt | NX_Q9NZT2. |
| PharmGKB | PA31911. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG07195. |
| GeneTree | ENSGT00390000018730. |
| HOVERGEN | HBG024736. |
| InParanoid | Q9NZT2. |
| OMA | RCKFVWG. |
| OrthoDB | EOG4FBHTH. |
| PhylomeDB | Q9NZT2. |
Gene expression databases | |
| ArrayExpress | Q9NZT2. |
| Bgee | Q9NZT2. |
| Genevestigator | Q9NZT2. |
| GermOnline | ENSG00000060491. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR006757. OGF_rcpt. IPR006770. OGF_rcpt_rpt. [Graphical view] |
| Pfam | PF04680. OGFr_III. 7 hits. PF04664. OGFr_N. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 41999. |
| SOURCE | Search... |
Entry information
| Entry name | OGFR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9NZT2 Secondary accession number(s): O96029 Q9NZT4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with